TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive In Brief: ASTRO Officers Named; AACR Fellowships Available; NRC Won’t Revoke NIH License November 10, 1995
TCL Archive SBRT Delivers Higher Overall Survival Rates Compared to Conventional Radiation Therapy November 30, 2012
